COVID-19 pandemic
Health Canada approves the use of the Pfizer–BioNTech vaccine for children ages 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.
Sources: CTV News
Changes
- Health Canada approves the use of the Pfizer–BioNTech vaccine for children age 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.
- Health Canada approves the use of the Pfizer–BioNTech vaccine for children ages 12 to 15, becoming the first country to approve the vaccine for use in younger age groups.